Andrew Park
Foot & Ankle Surgery · Covington, WANPI 1124400858
Payments from drug & device makers
What this record shows
This record is dominated by education: $5,481 of the $5,888 with a category attached, or 93.1%. Goode Surgical Inc accounts for 93.1% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $5,649 and has fallen 99.7% since, to $19 in 2025.
Across 10 payments — averaging $588.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Goode Surgical Inc$5K
- Abbott$168
- Nevro Corp.$101
- Invictus Surgical Incorporated$46
- Stryker$41
- Organogenesis Inc.$33
- plus $19 from 1 others
What the payments were for
- Food & beverage$4077%
- Education$5,48193%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Goode Surgical Inc | 1 | $5,481 |
| Abbott | 3 | $168 |
| Nevro Corp. | 1 | $101 |
| Invictus Surgical Incorporated | 1 | $46 |
| Stryker | 1 | $41 |
| Organogenesis Inc. | 2 | $33 |
| Smith+Nephew | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axium Sheath Braided DRG$157
- Senza$101
How this compares
$5,888 in reported general payments places this provider in the 75th percentile of 203 foot & ankle surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 34 | $1,146 |
| Terbinafine Hcl | 23 | $682 |
| Mupirocin | 40 | $324 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $126 |
| Doxycycline Hyclate | 15 | $88 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $83 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Covington
- Jeffrey ChristensenEverett$828K
- David DalstromSeattle$491K
- Richard LamourOlympia$87K
- Adam AlbabaSeattle$46K
- Stephen BenirschkeSeattle$45K
- Craig CliffordFederal Way$44K
- Shawn KhademiRenton$43K
- Gregory GrabowskiBellevue$34K
- Jacob McLeodLongview$34K
- Garrett PereskoMorton$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.